Eisai’s Lecanemab phase 3 study meets primary endpoint
Results show reduction of clinical decline in global study of people with Alzheimer’s Disease
Read More
Author: John Pinching
Research reveals chaotic schedule for myeloma patients
Myeloma diagnosis can take over five months, requiring several medical consultations
Read More
Modus completes recruitment for sevuparin study
Phase 1b study evaluates effects of sevuparin on the symptoms of volunteer participants
Read More
Navigo and Mannin agree to develop a novel drug for treating COVID-19
Precision X affinity ligand will enable the efficient purification of the non-Fc fusion protein
Read More
Tilt collaborates with MSD on immunotherapy clinical trial
The study will focus on checkpoint inhibitor refractory non-small cell lung cancer
Read More- Laigo Bio completes final close of €17m seed financing round
- Axplora announces expansion as newest part of $60m API investment programme
- DNA Script signs SYNTAX distribution agreements with Gencell, BMS and Biostream
- Ondine’s Steriwave phase 3 trial reaches 93% enrolment milestone
- Arvinas reports strong phase 1 results for ARV-102 in Parkinson’s disease
